Highlights of Ending Age-Related Diseases 2020
Key points from 20 presentations from world-leading researchers
Join the club for FREE to access the whole archive and other member benefits.
Co-founder and CEO of Juvena Therapeutics
Dr. Hanadie Yousef is a trained stem cell biologist, neurobiologist, and chemical biologist with a focus on the mechanisms of aging, with multiple issued and pending patents and several publications on methods for tissue rejuvenation during the last 17 years conducting research in numerous prestigious institutions.
Dr. Yousef earned a BS in chemistry with a minor in Spanish from Carnegie Mellon University, a PhD in Molecular and Cell Biology from UC Berkeley, a 4.5-year postdoctoral fellowship at Stanford School of Medicine in Neurology, and has worked in R&D at Regeneron and Genentech. In 2017, Dr. Yousef co-founded Juvena Therapeutics, Inc., to pursue her dream to build a revolutionary biopharmaceutical company that develops new medicines to promote tissue regeneration and increase healthspan in the elderly.
Visit website: https://www.juvenatherapeutics.com/hyousefbio
See also: Juvena Therapeutics - Biopharma discovering novel protein-based therapeutics that promote tissue regeneration
Details last updated 11-Feb-2020
31-May-2023 to 02-Jun-2023
Event about aging and aging related diseases organized by Hanson Wade
29-Nov-2023 to 30-Nov-2023
Longevity summit organised by Hevolution Foundation (Riyadh,Saudi Arabia)
13-Jun-2024 to 16-Jun-2024
Event gathering Global Longevity and Rejuvenation community in Dublin by LEV Foundation (Dublin, Ireland)
11-Oct-2021 to 14-Oct-2021
The Kitalys institute virtual conference targeting key questions that will impact the future of aging and extending healthspan
03-Dec-2024 to 04-Dec-2024
Longevity researchers, investors, and entrepreneurs speaking about eliminating disease of ageing by Longevity Global (Novato, CA, USA)
Hanadie Yousef delivered a keynote on therapeutic leads from the stem cell secretome
Key points from 20 presentations from world-leading researchers
Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few years
Another reminder of the amount of research, with multiple approaches, about to go into clinical trials
Its a fully integrated approach for developing biologics for chronic and age-related diseases
Muscle regeneration would have a huge hit on healthspan - getting people more mobile again
Attempts have been made to rejuvenate the body by transfusing old people with young blood. Recen...